Relay Therapeutics, Inc. ($RLAY)
Filing Information
| Accession Number | 0001193125-26-150044 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 10, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
23,117
Total Value
$266,894.17
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Apr 7, 2026 | Sale | 17,717 | $13.01 | $230,498.17 | 213,867 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 9, 2026 | Exercise/Conversion | 1,800 | $5.22 | $9,396.00 | 215,667 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 9, 2026 | Sale | 1,800 | $15.00 | $27,000.00 | 213,867 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Apr 9, 2026 | Exercise/Conversion | 1,800 | $0.00 | $0.00 | 61,563 | Direct | โ | View Details |